YY8-62794-28980
5 vaccinations
5 coded responses
35 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 287 / NC
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Moderna
-
2021-01-21
Registered in v-safe
- 2021-01-22
- 2021-01-23
- 2021-01-24
-
2021-01-25
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: GoodFree text: In retrospect, I realize that I had a vague headache on the day after given the vaccine. It was not severe enough to take anything for it.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-01-27
-
2021-02-03
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling — Feeling: GoodFree text: Starting 1/28 there was slight swelling @ vaccination site and a red blotch approximately 2x4 inches below vaccination site. It became itchy on 1/29, faded to pink on 1/31 and is no longer itchy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
-
2021-02-17
Dose 2 — Moderna
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-05
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-05-19
- 2021-08-18
-
2021-11-20
Dose 3 — Moderna
- 2022-02-17
-
2022-04-11
Dose 4 — Moderna
- 2022-04-28
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-07-11
-
2022-09-12
Dose 5 — Pfizer-BioNTech
- 2022-10-10
-
2022-10-21
Survey response — day 35, dose 5MedDRA: Pain in extremity — Feeling: GoodFree text: Right foot pain, possibly plantar fasciitisMedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
-
2022-12-12
Survey response — 3 months, dose 5MedDRA: Atrial fibrillation, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: A. Fib · Healthcare visit (other): Cardiology referralMedDRA releases: 2024-11 · check-in free text available
-
2022-12-12
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-13
-
2023-03-13
Survey response — 6 months, dose 5MedDRA: Atrial fibrillation, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-13
Report sent to call center — 6 months, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-03-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-03-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-17 | Moderna | |
| 3 | 2021-11-20 | Moderna | No |
| 4 | 2022-04-11 | Moderna | No |
| 5 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-12 | Successful 2023-03-15 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-03-13 | Successful 2023-03-15 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): In retrospect, I realize that I had a vague headache on the day after given the vaccine. It was not severe enough to take anything for it.
Release 3 — day 14, dose 1
Symptoms: Starting 1/28 there was slight swelling @ vaccination site and a red blotch approximately 2x4 inches below vaccination site. It became itchy on 1/29, faded to pink on 1/31 and is no longer itchy.
Release 12 — day 35, dose 5
Symptoms: Right foot pain, possibly plantar fasciitis
Release 12 — 3 months, dose 5
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Atrial fibrillation | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release